Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in Chemotherapy-Induced Peripheral ... (lammatory and neuropathic pain states an...)

Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in Chemotherapy-Induced Peripheral Neuropathy

Date:12/10/2012

lammatory and neuropathic pain states and these fundamental studies support not only the EMA401 clinical program but also Spinifex's ongoing AT₂ receptor antagonist drug discovery program.

Spinifex Pharmaceuticals

Spinifex Pharmaceuticals is an Australian biotechnology company developing new drug candidates for the treatment and management of pain.

Established in 2005 and based in Melbourne, Spinifex has applied its world-class drug development capabilities to advance product candidates. Its lead product EMA401 is under development as a potential first-in-class oral treatment for chronic pain, including neuropathic pain, without CNS side effects. Spinifex's Phase 2 program for EMA401 includes clinical trials in a number of neuropathic pain conditions. Spinifex investors are GBS Venture Partners, Brandon Capital Partners, Uniseed and UniQuest.

http://www.spinifexpharma.com.au

For more information please contact:

Company
Dr Tom McCarthy
CEO Spinifex Pharmaceuticals
Tel: +61-(0)3-9938-1205
Email: tom.mccarthy@spinifexpharma.com.au

Media
Chris Gardner/Nina Enegren
Citigate Dewe Rogerson
Tel: +44-(0)20-7638-9571
Email: nina.enegren@citigatedr.co.uk

SOURCE Spinifex Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Seahorse Bioscience Announces Asia Mito 2012 Travel Award Winners Advancing Cell Metabolism Research
2. Blue Belt Technologies Announces Golden Jubilee National Hospital Completes Initial NavioPFS Unicondylar Knee Replacement Surgery
3. Northwest Biotherapeutics Announces Public Offering of Common Stock and Warrants, and Listing on NASDAQ
4. AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock
5. PTC Therapeutics Announces European Medicines Agency Validation of Marketing Authorization Application for Ataluren in Duchenne Muscular Dystrophy
6. Omeros Announces Encouraging Data from Phase 1 Clinical Trial for PDE10 Program
7. OrthoAccel Technologies, Inc. Announces Appointment of New Chief Financial Officer
8. Cerecor Announces Option to Johns Hopkins Brain Science Institute DAAO Inhibitor Platform
9. Savient Announces the Election of Robert G. Savage to its Board of Directors
10. Harrington Discovery Institute at University Hospitals Case Medical Center Announces Grant Funding to Physician-Scientists at Major Academic Medical Centers to Support New Drug Development
11. Braincells, Inc. Announces the Successful Completion of a Multiple Ascending Dose Study of BCI-838, a Group II mGluR2/3 Antagonist, and the Companys Plans for a Proof-of-Concept Study in Patients with Treatment-Resistant Depression

Post Your Comments:

(Date:5/23/2013)... DIEGO and PARIS , ... VOLC ), a leading developer and manufacturer of precision ... treatment of coronary and peripheral vascular disease, today announced ... V asodilator I ndependent S tenosis ... breaking clinical trial session at EuroPCR 2013. These prospective ...

(Date:5/23/2013)... -- Nederland keurt als eerste nieuwe vaste-dosis ... BPH Astellas Pharma EUROPE ... gebaseerd in Tokyo ( ... Nederlandse College ter Beoordeling van Geneesmiddelen (CBG) een handelsvergunning ... handelsvergunning verleend voor VESOMNI is voor "de behandeling van ...

(Date:5/23/2013)... , Switzerland and ... 2013 Cenix BioScience, a ... specialized in RNAi-, miRNA- and high content-driven pharmacology, ... group of companies with a focus on the ... needs, including oncology and companion diagnostics, today announced ...

Breaking Medicine Technology:Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 2 Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 3 Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 4 Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 5 Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 2 Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 3 Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 4 Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 2 Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 3 Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 4

[0] Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 [0] Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen [0] Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers

... ... ... ... ...

Cached Medicine Technology:Diabetics Twice as Likely to Have Hearing Loss; Pennsylvania HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 2 Diabetics Twice as Likely to Have Hearing Loss; Pennsylvania HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 3 Diabetics Twice as Likely to Have Hearing Loss; Pennsylvania HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 4 Diabetics Twice as Likely to Have Hearing Loss; Pennsylvania HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 5 Instrumentation Laboratory Receives 510(K) Clearance From FDA and Canadian License for HemosIL(R) D-Dimer HS 500 Assay 2 Instrumentation Laboratory Receives 510(K) Clearance From FDA and Canadian License for HemosIL(R) D-Dimer HS 500 Assay 3 Instrumentation Laboratory Receives 510(K) Clearance From FDA and Canadian License for HemosIL(R) D-Dimer HS 500 Assay 4

Diabetics Twice as Likely to Have Hearing Loss; Pennsylvania HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March Instrumentation Laboratory Receives 510(K) Clearance From FDA and Canadian License for HemosIL(R) D-Dimer HS 500 Assay

(Date:5/23/2013)... Wisconsin (PRWEB) May 23, 2013 Great defined ... is what almost everyone strives to achieve in the gym ... of crunches will not make this goal become a reality. ... habits that are often time overlooked. Scott Tischler of Tischler ... be done to achieve the goal of great abs. , ...

(Date:5/23/2013)... PhD Box has introduced a service that ... process by offering assistance for Thesis Proposals. The proposal writing ... that the company provides for research consultation in various fields. ... writing service is that this is the stage where most ... find it difficult to draft a proposal as it is ...

(Date:5/23/2013)... May 23, 2013 Indosoft Inc., ... for Asterisk telephony, announces major enhancements ... Monitoring and Decision Making System that allows mission ... offer call survival. The new enhancements strengthen automatic ... thereby enhancing reliability. , Large call centers using ...

(Date:5/23/2013)... Georgia (PRWEB) May 23, 2013 Long-Term ... disturbing downtrend in the rate at which applicants for Long ... to buy coverage. , The decision to buy ... decision, but even consumers willing and able to purchase protection ... buy a policy at any price. A variety of ...

(Date:5/23/2013)... Get ready to sweat. , Automatic ... in conjunction with the Nutrié California Kick Off ... participants will get the chance to work out with ... The Dr. Oz Show, and The Dr. Phil Weight ... the undefeated UFC heavy-weight contender Daniel Cormier at Chukchansi ...

Breaking Medicine News(10 mins):Health News:Scott Tischler of Tischler Brothers Fitness Unveils the 4 Secrets to Getting Abs this Summer 2 Health News:PhD Box Unveils Proposal Writing Services for Research Scholars 2 Health News:Indosoft Upgrades its Overseer Watchdog System for Q-Suite to Enhance High Availability with Call Survival for Mission Critical ACD Applications 2 Health News:More Baby Boomers Rejected by Long Term Care Insurance Companies 2 Health News:More Baby Boomers Rejected by Long Term Care Insurance Companies 3 Health News:Kim Lyons, Gunter Schlierkamp, & Daniel Cormier To Host Fresno Charity Workout 2 Health News:Kim Lyons, Gunter Schlierkamp, & Daniel Cormier To Host Fresno Charity Workout 3

[0] Scott Tischler of Tischler Brothers Fitness Unveils the 4 Secrets to Getting Abs this Summer [0] PhD Box Unveils Proposal Writing Services for Research Scholars [0] Indosoft Upgrades its Overseer Watchdog System for Q-Suite to Enhance High Availability with Call Survival for Mission Critical ACD Applications [0] More Baby Boomers Rejected by Long Term Care Insurance Companies [0] Kim Lyons, Gunter Schlierkamp, & Daniel Cormier To Host Fresno Charity Workout

... ... titanium ring studios shows that single women shop for engagement rings before meeting the partner they ... ... design studios, TiRings.com, has revealed evidence that shows a tendency among single women to shop for ...

... ... is the leading supplier of software & technology to Home Medical ... Health Care Agencies. Only Fastrack offers a solution for each ... virtually every clinical, operational and financial aspect of a provider’s business, ...

... The ... and other metal products. In addition to revealing the personality and culture of The Monterey ... pins, and an informal forum for discussions related to such products. , ... (PRWEB) May 8, 2010 -- This year has been a ...

... carbonated soft drinks is not associated with the risk of ... 7 in the Journal of the National Cancer Institute. ... and tea may lower the risk of cancer, but others ... contains anti-oxidants that in theory help prevent cancer but also ...

... ... Beauty, Fighting the Aging Process and Maintaining a Youthful, “Close-Up-Ready” Appearance , ... Los Angeles, CA (PRWEB) May ... have begun to open up about using non-surgical aesthetic procedures to maintain their youthful, ...

... ... religion’s first book this weekend. Published May 9, 1950, “Dianetics: The Modern Science of ... , ... 2010 -- Churches of Scientology around the world celebrate the original release of ...

Cached Medicine News:Health News:Statistics Reveal Women Choose Engagement Rings Before Men 2 Health News:Fastrack Acquires Prometheus Group Industry Leading HME Billing Service 2 Health News:Monterey Lapel Pin Company Continues Its Website Evolution 2 Health News:Monterey Lapel Pin Company Continues Its Website Evolution 3 Health News:Coffee and soft drinks have little or no association with colon cancer risk 2 Health News:Achieve Hollywood Glamour with Non-Surgical Cosmetic Procedures 2 Health News:Achieve Hollywood Glamour with Non-Surgical Cosmetic Procedures 3 Health News:Scientology Churches Celebrate Dianetics 60th Anniversary 2

Statistics Reveal Women Choose Engagement Rings Before Men Fastrack Acquires Prometheus Group Industry Leading HME Billing Service Monterey Lapel Pin Company Continues Its Website Evolution Coffee and soft drinks have little or no association with colon cancer risk Achieve Hollywood Glamour with Non-Surgical Cosmetic Procedures Scientology Churches Celebrate Dianetics 60th Anniversary

... 1-step, hand-held, point-of-care device for the qualitative detection ... The TOX/See device can detect up to ... 3 to 8 minutes and requires only a ... individually packaged to maximize convenience and ease of ...

... point-of-care device for the qualitative detection of drug ... TOX/See device can detect up to nine of ... 8 minutes and requires only a few drops ... to maximize convenience and ease of use. TOX/See ...

... hand-held, point-of-care device for the qualitative detection of ... The TOX/See device can detect up to nine ... to 8 minutes and requires only a few ... packaged to maximize convenience and ease of use. ...

... TOX/See™ is a 1-step, hand-held, point-of-care device ... metabolites in human urine. The TOX/See device ... commonly abused drugs in 3 to 8 minutes ... Each TOX/See cassette is individually packaged to maximize ...

Medicine Products:

TOX/See Drugscreen PCP TOX/See Drugscreen MDMA (Ecstasy)TOX/See Drugscreen BUP TOX/See Drugscreen BZO